NCT06995677
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06995677
Title Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer (SURF302)
Acronym SURF302
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Tyra Biosciences, Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA